Wells Fargo’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$248K Sell
62,724
-72,680
-54% -$366K ﹤0.01% 4580
2025
Q4
$917K Buy
135,404
+29,897
+28% +$210K ﹤0.01% 4037
2025
Q3
$736K Buy
105,507
+12,532
+13% +$87.1K ﹤0.01% 4024
2025
Q2
$568K Sell
92,975
-42,914
-32% -$285K ﹤0.01% 4048
2025
Q1
$1.03M Buy
135,889
+65,842
+94% +$550K ﹤0.01% 3635
2024
Q4
$674K Sell
70,047
-110,595
-61% -$862K ﹤0.01% 3982
2024
Q3
$1.07M Sell
180,642
-5,073
-3% -$33.6K ﹤0.01% 3505
2024
Q2
$1.29M Buy
185,715
+128,158
+223% +$901K ﹤0.01% 3319
2024
Q1
$443K Sell
57,557
-5,771
-9% -$46.4K ﹤0.01% 3973
2023
Q4
$555K Sell
63,328
-38,994
-38% -$286K ﹤0.01% 3791
2023
Q3
$746K Buy
102,322
+3,472
+4% +$25.9K ﹤0.01% 3525
2023
Q2
$653K Buy
98,850
+9,574
+11% +$48.8K ﹤0.01% 3759
2023
Q1
$304K Buy
89,276
+60,218
+207% +$233K ﹤0.01% 4172
2022
Q4
$80.8K Buy
29,058
+7,177
+33% +$21.5K ﹤0.01% 4640
2022
Q3
$63K Sell
21,881
-7
-0% -$25 ﹤0.01% 4841
2022
Q2
$76K Sell
21,888
-182,928
-89% -$716K ﹤0.01% 4807
2022
Q1
$966K Sell
204,816
-87,113
-30% -$426K ﹤0.01% 3928
2021
Q4
$1.76M Buy
291,929
+8,843
+3% +$61.4K ﹤0.01% 3620
2021
Q3
$1.72M Buy
283,086
+257,988
+1,028% +$2.91M ﹤0.01% 3796
2021
Q2
$314K Buy
25,098
+8,115
+48% +$87.9K ﹤0.01% 4849
2021
Q1
$175K Buy
16,983
+3,947
+30% +$38.1K ﹤0.01% 5220
2020
Q4
$119K Buy
+13,036
New +$93.8K ﹤0.01% 5290
2018
Q4
Sell
-1,108,911
Closed -$6.85M 6528
2018
Q3
$6.85M Buy
1,108,911
+349,477
+46% +$1.58M ﹤0.01% 2388
2018
Q2
$4.85M Sell
759,434
-347,671
-31% -$2.47M ﹤0.01% 2712
2018
Q1
$7.72M Buy
1,107,105
+153,715
+16% +$1.79M ﹤0.01% 2240
2017
Q4
$12M Buy
953,390
+238,110
+33% +$2.9M ﹤0.01% 1864
2017
Q3
$8.5M Buy
715,280
+37,743
+6% +$560K ﹤0.01% 2100
2017
Q2
$10.1M Buy
677,537
+206,406
+44% +$2.75M ﹤0.01% 1894
2017
Q1
$4.49M Buy
471,131
+41,028
+10% +$346K ﹤0.01% 2514
2016
Q4
$3.81M Sell
430,103
-664,681
-61% -$5.97M ﹤0.01% 2618
2016
Q3
$9.39M Buy
1,094,784
+60,415
+6% +$478K ﹤0.01% 1803
2016
Q2
$8.25M Sell
1,034,369
-59,892
-5% -$466K ﹤0.01% 1972
2016
Q1
$9.56M Buy
1,094,261
+52,715
+5% +$438K ﹤0.01% 1848
2015
Q4
$9.76M Buy
1,041,546
+169,102
+19% +$1.47M ﹤0.01% 1856
2015
Q3
$8.42M Buy
872,444
+2,732
+0.3% +$28.8K ﹤0.01% 1939
2015
Q2
$10.1M Buy
869,712
+491,356
+130% +$5.06M ﹤0.01% 1908
2015
Q1
$3.94M Buy
378,356
+38,986
+11% +$365K ﹤0.01% 2548
2014
Q4
$3.91M Buy
339,370
+71,040
+26% +$702K ﹤0.01% 2531
2014
Q3
$1.91M Buy
268,330
+30,165
+13% +$210K ﹤0.01% 3025
2014
Q2
$1.69M Buy
238,165
+61,040
+34% +$357K ﹤0.01% 3108
2014
Q1
$1.08M Buy
177,125
+15,529
+10% +$114K ﹤0.01% 3435
2013
Q4
$1.41M Sell
161,596
-471,813
-74% -$2.89M ﹤0.01% 3179
2013
Q3
$2.64M Buy
633,409
+632,709
+90,387% +$3.49M ﹤0.01% 2691
2013
Q2
$5K Buy
+700
New +$4.89K ﹤0.01% 5215

Other funds holding MDXG

Wells Fargo's MDXG Position: Q1 2026 in Review

Wells Fargo reduced its MiMedx Group (MDXG) stake by 54% in Q1 2026, selling an estimated $366K and leaving 62,724 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #4580.

Wells Fargo first reported a position in MDXG in Q2 2013 and has held it in 44 quarters since. The position peaked at $12M in Q4 2017. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Wells Fargo held 62,724 shares of MiMedx Group worth $248K as of Q1 2026.
  • Wells Fargo sold 72,680 MiMedx Group shares in Q1 2026, an estimated $366K.
  • MiMedx Group made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4580 holding.
  • Wells Fargo first reported a position in MiMedx Group in Q2 2013 and has held it in 44 quarters since.
  • Wells Fargo's MiMedx Group position peaked at $12M in Q4 2017.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.